CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (France)
SORBONNE UNIVERSITE (France)
COLLEGE DE FRANCE (France)
ECOLE NORMALE SUPERIEURE (France)
Inventor
Machu, Yohann
Sayrin, Clément
Brune, Michel
Abstract
The invention relates to a method for holographic generation of an array of focusing points arranged according to multiple positions of the field of an optical system, which comprises: (S10) detecting images formed by the optical system at a plurality of calibration points arranged according to multiple positions of the field of the optical system; (S20) estimating aberrations introduced by the optical system onto the optical field from the detected images; (S30) applying a phase mask to the optical beam in order to generate a plurality of focusing points arranged according to multiple positions in the field of the optical system; wherein the phase mask is calculated from the estimated aberrations in order to simultaneously compensate for the aberrations at each focusing point. The invention also relates to a holographic generation system which carries out this method.
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (France)
COLLEGE DE FRANCE (France)
ECOLE NORMALE SUPERIEURE (France)
SORBONNE UNIVERSITE (France)
Inventor
Barbosa De Aguiar, Hilton
Bruschini, Claudio
Charbon, Edoardo
Burri, Samuel
Abstract
An apparatus for detecting one or more chemicals in a sample, the apparatus including: a scanning unit including a light source configured to scan the sample using a light beam having a linear-shaped illumination; a dispersive element configured to receive light from the sample and disperse the received light spatially in a parallel manner; a spatial light modulator configured to receive the dispersed light and select one or more wavelength bands of the dispersed light; and a detection unit including a one-dimensional array of detectors configured to receive the selected one or more wavelength bands and detect the one or more chemicals in the sample based on the selected one or more wavelength bands, each detector of the array of detectors being a photon detector having a detection surface having a dimension below 50 μm, the dimension being in a direction of the linear-shaped illumination.
G01N 3/44 - Investigating hardness or rebound hardness by performing impressions under a steady load by indentors, e.g. sphere, pyramid the indentors being put under a minor load and a subsequent major load, i.e. Rockwell system
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (France)
COLLEGE DE FRANCE (France)
SORBONNE UNIVERSITÉ (France)
Inventor
Tarascon, Jean-Marie
Mariyappan, Sathiya
Forero-Saboya, Juan
Abstract
An electrolyte composition which comprises a non-aqueous organic solvent, a conducting electrolyte salt, and at least one additive of formula (I): wherein M is a metal, X is H or -O-R and R is an alkyl and an electrochemical device comprising the electrolyte composition.
H01M 10/0567 - Liquid materials characterised by the additives
H01M 10/0525 - Rocking-chair batteries, i.e. batteries with lithium insertion or intercalation in both electrodesLithium-ion batteries
H01M 4/525 - Selection of substances as active materials, active masses, active liquids of inorganic oxides or hydroxides of nickel, cobalt or iron of mixed oxides or hydroxides containing iron, cobalt or nickel for inserting or intercalating light metals, e.g. LiNiO2, LiCoO2 or LiCoOxFy
H01M 10/0568 - Liquid materials characterised by the solutes
H01M 10/0569 - Liquid materials characterised by the solvents
4.
ADVANCED CELL FOR ELECTROCHEMICAL CHARACTERIZATION OF BATTERY INTERFACE VIA EQCM
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (France)
COLLEGE DE FRANCE (France)
SORBONNE UNIVERSITE (France)
Inventor
Tarascon, Jean-Marie
Sel, Ozlem
Bendadesse, Ezzoubair
Travers, Pascal
Abstract
The invention concerns a test cell for an EQCM of an electrochemical system comprising a liquid electrolyte. It comprises: - a cell body (10) comprising an electrolyte cavity (11), a quartz resonator (12) coated with a first working electrode (FW) with an active material to be tested and being configured to provide a signal function of a mass variation of the first working electrode (FW), - a cell basis (20) comprising a connecting terminal (22) receiving the signal from the quartz resonator (12), The test cell (8) also comprises a cell holder (30), comprising: - a second electrolyte cavity connecting with the first electrolyte cavity, - a second working electrode, connected to the quartz resonator through the first and second electrolyte cavity (11), comprising similar material to the active material to be tested, - a counter electrode connected to the quartz resonator through the first and second electrolyte cavities (11).
G01N 29/036 - Analysing fluids by measuring frequency or resonance of acoustic waves
G01N 29/22 - Investigating or analysing materials by the use of ultrasonic, sonic or infrasonic wavesVisualisation of the interior of objects by transmitting ultrasonic or sonic waves through the object Details
H01M 10/52 - Removing gases inside the secondary cell, e.g. by absorption
5.
METHOD FOR OPERANDO CHARACTERIZATION OF CHEMICAL SPECIES WITHIN A BATTERY USING INFRARED EVANESCENT WAVE SPECTROSCOPY
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (France)
COLLÈGE DE FRANCE (France)
SORBONNE UNIVERSITÉ (France)
UNIVERSITÉ DE RENNES 1 (France)
ECOLE NATIONALE SUPERIEURE DE CHIMIE DE RENNES (France)
INSTITUT NATIONAL DES SCIENCES APPLIQUEES DE RENNES (France)
Inventor
Tarascon, Jean-Marie
Gervillie, Charlotte
Boussard, Catherine
Zhang, Xiang-Hua
Adam, Jean-Luc
Abstract
Method for operando characterization of the chemical composition of a battery cell, comprising the following steps: inserting an optical fiber made of chalcogenide glass through the battery cell, cycling the battery, while cycling the battery, generating an optical signal and transmitting it through the optical fiber, detecting, using an infrared spectrometer, the transmitted optical signal at an output extremity of the optical fiber, recording the detected optical signal over time, locating, using fiber evanescent wave spectroscopy, signature wavelengths for which the optical signal intensity is above a predetermined threshold within the spectrum, associating the located signature wavelengths to at least one predetermined chemical species.
G01N 21/25 - ColourSpectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
G01N 21/31 - Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
G01N 21/35 - Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light
G01N 21/3563 - Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light for analysing solidsPreparation of samples therefor
H01M 10/48 - Accumulators combined with arrangements for measuring, testing or indicating the condition of cells, e.g. the level or density of the electrolyte
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (France)
COLLEGE DE FRANCE (France)
SORBONNE UNIVERSITE (France)
Inventor
Aguilar, Ivette
Brown, John
Tarascon, Jean-Marie
Abstract
22 electrochemical device said electrolyte comprising water, zinc sulphate and urea, its use and an electrochemical device comprising said electrolyte.
The invention relates to a process for electrolysing carbon oxides selected from carbon monoxide and/or carbon dioxide into ethylene by means of an electrolyser comprising a cathode catalyst being a dendritic copper oxide catalyst or a dendritic copper catalyst.
C23C 28/00 - Coating for obtaining at least two superposed coatings either by methods not provided for in a single one of main groups , or by combinations of methods provided for in subclasses and
C25B 9/19 - Cells comprising dimensionally-stable non-movable electrodesAssemblies of constructional parts thereof with diaphragms
C25B 9/23 - Cells comprising dimensionally-stable non-movable electrodesAssemblies of constructional parts thereof with diaphragms comprising ion-exchange membranes in or on which electrode material is embedded
C25B 11/075 - Electrodes formed of electrocatalysts on a substrate or carrier characterised by the electrocatalysts material consisting of a single catalytic element or catalytic compound
C25D 3/38 - ElectroplatingBaths therefor from solutions of copper
C25D 5/50 - After-treatment of electroplated surfaces by heat-treatment
8.
MICROFLUIDIC DEVICE FOR USE IN A SYSTEM FOR MEASURING AT LEAST ONE MECHANICAL PROPERTY OF AT LEAST ONE OOCYTE
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (France)
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (France)
Inventor
Barbier, Lucie
Bulteau, Rose
Campillo, Clément
Terret, Marie-Emilie
Verlhac, Marie-Hélène
Abstract
The present invention relates to a microfluidic device (100) for use in a system for measuring at least one biomarker, of at least one oocyte, said microfluidic device (100) comprising at least one microfluidic channel (43) configured for a passage of a flow of fluid comprising at least one oocyte, the microfluidic channel (43) comprising a restriction section (50) configured to deform the oocyte in at least a first direction and a second direction perpendicular to a microfluidic channel axis, the first direction being different from the second direction.
The disclosure relates to a gas diffusion electrode—GDE—suitable for carbon dioxide electrolysis, said gas diffusion electrode having a gas diffusion membrane, the gas diffusion electrode further comprising an ink (19) deposited on the gas diffusion membrane; wherein the ink comprises an ion-conducting polymer and copper nanoparticles functionalized with one or more pyridine-containing ligands, wherein the one or more pyridine-containing ligands have an anchoring group comprising one sulphur atom tethered to the copper nanoparticles. The disclosure also relates to a gas-fed flow cell comprising such gas diffusion electrode and to a method for producing such GDE as well to the electrolysis of carbon dioxide using such GDE.
C25B 9/19 - Cells comprising dimensionally-stable non-movable electrodesAssemblies of constructional parts thereof with diaphragms
C25B 11/075 - Electrodes formed of electrocatalysts on a substrate or carrier characterised by the electrocatalysts material consisting of a single catalytic element or catalytic compound
10.
Oxygen evolution reaction electrode catalyst assembly comprising dendritic nickel foam, its use and a method to produce said assembly
The present disclosure relates to a method to produce an oxygen evolution reaction electrode catalyst assembly comprising a dendritic nickel foam. The method is remarkable in that it comprises the steps of (a) providing a dendritic nickel foam material; (b) etching the dendritic nickel foam material by placing it in a etch solution being an acidic aqueous solution or an aqueous solution of metal chloride and recovering an etched dendritic nickel foam with nickel dendrites showing a chimney-like structure.
G02F 1/1506 - Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulatingNon-linear optics for the control of the intensity, phase, polarisation or colour based on an electrochromic effect based on electrodeposition, e.g. electrolytic deposition of an inorganic material on or close to an electrode
G02F 1/1516 - Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulatingNon-linear optics for the control of the intensity, phase, polarisation or colour based on an electrochromic effect characterised by the electrochromic material, e.g. by the electrodeposited material comprising organic material
G02F 1/1523 - Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulatingNon-linear optics for the control of the intensity, phase, polarisation or colour based on an electrochromic effect characterised by the electrochromic material, e.g. by the electrodeposited material comprising inorganic material
G02F 1/15 - Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulatingNon-linear optics for the control of the intensity, phase, polarisation or colour based on an electrochromic effect
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (France)
COLLEGE DE FRANCE (France)
SORBONNE UNIVERSITE (France)
Inventor
Marchandier, Thomas
Ouspenski, Vladimir
Tarascon, Jean-Marie
Hannequart, Benjamin
Abstract
The present invention relates to an all-solid-state-battery (ASSB) comprising successively: an anode comprising lithium in the metallic state, at least one solid electrolyte layer comprising a solid electrolyte material, and a cathode composite comprising a cathode active material and a halide solid electrolyte, wherein the all- solid-state-battery is submitted to a pressure comprised from 0.05 MPa to 30 MPa. The invention further pertains to a process of making said ASSB comprising assembling a cell comprising the ASSB and applying a pressure ranging from 0.05 MPa to 30 MPa onto the assembled cell.
H01M 4/131 - Electrodes based on mixed oxides or hydroxides, or on mixtures of oxides or hydroxides, e.g. LiCoOx
H01M 4/134 - Electrodes based on metals, Si or alloys
H01M 4/38 - Selection of substances as active materials, active masses, active liquids of elements or alloys
H01M 4/525 - Selection of substances as active materials, active masses, active liquids of inorganic oxides or hydroxides of nickel, cobalt or iron of mixed oxides or hydroxides containing iron, cobalt or nickel for inserting or intercalating light metals, e.g. LiNiO2, LiCoO2 or LiCoOxFy
H01M 4/62 - Selection of inactive substances as ingredients for active masses, e.g. binders, fillers
H01M 10/0585 - Construction or manufacture of accumulators having only flat construction elements, i.e. flat positive electrodes, flat negative electrodes and flat separators
13.
USE OF AMPHIREGULIN (AREG) IN METHODS OF TREATING VASCULAR HYPERPERMEABILITY
INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE (France)
ASSISTANCE PUBLIQUE-HÔPITAUX DE PARIS (APHP) (France)
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (France)
UNIVERSITÉ PARIS CITÉ (France)
COLLÈGE DE FRANCE (France)
Inventor
Germain, Stéphane
Brechot, Nicolas
Abstract
The disruption of endothelial barrier integrity leading to increased vascular permeability contributes to many pathological processes. In a first cohort of 11 patients having cardiac arrest with vascular leakage, the inventors identified that AREG is 56-fold more expressed than control. During a second prospective clinical study, they confirmed a strong association between the plasma level of AREG and the fluid balance in 77 independent patients hospitalized for a cardiogenic shock. The inventors finally showed a crucial role for this protein in Areg-/- mice, with i) no KO-mice achieving a return of spontaneous circulation (ROSC) vs. 40% in WT mice (n=6 per group, p<0.05) and ii) a beneficial effect of 10 µg recombinant AREG i.v. injection at the time of resuscitation, with 80% injected mice that achieve a ROSC vs 40% in controls (n=6, p<0.05). Finally, using markers of vascular extravasation, they demonstrated that AREG administration was decreasing the level of vascular leakage. The results thus indicate that administering AREG in a patient suffering from vascular permeability would be beneficial. Thus, the present invention relates to the use of amphiregulin (AREG) in methods of treating vascular permeability.
A61K 38/17 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from animalsPeptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from humans
A61P 9/00 - Drugs for disorders of the cardiovascular system
A61P 9/10 - Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
A61P 9/14 - VasoprotectivesAntihaemorrhoidalsDrugs for varicose therapyCapillary stabilisers
USE OF THE RECOMBINANT FIBRINOGEN-LIKE DOMAIN OF ANGIOPOIETIN-LIKE 4 FOR TREATING ADVERSE POST-ISCHEMIC CARDIAC REMODELING IN A PATIENT WHO EXPERIENCED A MYOCARDIAL INFARCTION
INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE (France)
ASSISTANCE PUBLIQUE-HÔPITAUX DE PARIS (APHP) (France)
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (France)
COLLÈGE DE FRANCE (France)
ECOLE NATIONALE VÉTÉRINAIRE D'ALFORT (France)
UNIVERSITÉ PARIS-EST CRÉTEIL VAL DE MARNE (France)
Inventor
Germain, Stéphane
Ghaleh-Marzban, Bijan
Abstract
Ischemic heart diseases are leading causes of death and reduced life quality worldwide. Although revascularization strategies significantly reduce mortality after acute myocardial infarction (MI), a large number of patients with MI develop chronic heart failure over time. The inventors previously reported that human recombinant ANGPTL4 counteracts ischemia-induced vascular endothelial growth factor signaling and disruption of endothelial cell junctions thus inhibiting vascular permeability. When administered before MI, the inventors could show that ANGPTL4 leads to protection of the coronary capillary network, reduction of no-reflow and infarct size in mice. The inventors also showed that the therapeutic effects observed with ANGPTL4 in ischemic conditions are not due to the CCD fragments but are brought by the FLD fragment (WO2016/110498). To further test the therapeutic potential of the FLD of ANGPTL4 at the onset of reperfusion, the inventors here used a pig model in a clinically relevant model of acute myocardial infarction which can be easily and safely translated to patient treatment. The inventors demonstrated that local (antegrade) delivery of FLD ANGPTL4 to the infarcted pig heart can target the affected regions in an efficient and clinically relevant manner. A single dose of FLD of ANGPTL4 improved heart function, infarct size, fibrosis, and adverse remodeling parameters 28 days after MI. Short term MI experiments along with complementary murine studies revealed myocardial protection. Thus, a single dose of FLD of ANGPTL4 is capable of reducing ischemia-reperfusion injury and protects against deleterious post-ischemic cardiac remodeling and consecutive ischemic heart failure.
A61K 31/7105 - Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
A61P 9/10 - Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
A61K 9/00 - Medicinal preparations characterised by special physical form
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (France)
COLLÈGE DE FRANCE (France)
SORBONNE UNIVERSITÉ (France)
Inventor
Mariyappan, Sathiya
Tarascon, Jean-Marie
Hijazi, Hussein
Abstract
An electrolyte composition including at least one sodium salt dissolved in a solvent and a combination of additives, wherein: the solvent includes at least one compound selected from the group consisting of ethylene carbonate, dimethyl carbonate, ethyl methyl carbonate, diethyl carbonate, propylene carbonate, a carboxylate ester such as methyl acetate, ethyl acetate, ethyl propionate and methyl propionate, 4-fluorotoluene, 1,1,2,2-tetrafluoroethyl 2,2,3,3-tetrafluoropropyl ether, di-fluoro ethylene carbonate, ethyl difluoroacetate and diglyme, and the combination of additives comprises at least tris(trimethylsilyl)phosphite (TMSPi) and succinonitrile (SN).
The disclosure relates to a catalyst suitable for electrochemical reduction reactions of one or more carbon oxides, comprising a nitride-doped multi-metallic material comprising a primary metal being copper and one or more secondary metals selected from silver, gold, platinum, palladium, ruthenium, iridium, osmium, and any mixture thereof, wherein the nitride-doped multi-metallic material comprises, as determined by XRD, copper, copper nitride and copper- Me alloy wherein Me is one of the secondary metals and to a gas diffusion electrode suitable for electrolysis of one or more carbon oxides comprising such a catalyst.
C25B 9/23 - Cells comprising dimensionally-stable non-movable electrodesAssemblies of constructional parts thereof with diaphragms comprising ion-exchange membranes in or on which electrode material is embedded
C25B 11/097 - Electrodes formed of electrocatalysts on a substrate or carrier characterised by the electrocatalysts material consisting of at least one catalytic element and at least one catalytic compoundElectrodes formed of electrocatalysts on a substrate or carrier characterised by the electrocatalysts material consisting of two or more catalytic elements or catalytic compounds comprising two or more noble metals or noble metal alloys
The disclosure relates to a process for electrolysing carbon dioxide using a gas-fed flow cell comprising a gas diffusion electrode comprising a metal-based catalyst, wherein the catholyte flow is an acidic catholyte flow comprising one or more alkali metal cations, wherein the gas-fed flow cell comprises a bipolar membrane and wherein the acidic catholyte has a pH of at most 5.5 and the catholyte pH is less than the anolyte pH.
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (France)
COLLEGE DE FRANCE (France)
SORBONNE UNIVERSITÉ (France)
Inventor
Mariyappan, Sathiya
Grepin, Elisa
Tarascon, Jean-Marie
Abstract
The invention relates to a sodium layered oxide of formula I: NaxM1a+i-y-z-nM2b+yM3c+zM4d+nO2, wherein: M1a+, M2b+, M3c+and M4d+ are different transition metal ions or mixtures thereof, x is a number ranging from 0.5 to less than 1; y, z and n are numbers ranging from 0.01 to 0.85; y + z + n is less than 1; a, b, c and d are the respective oxidation number of the transition metal ions M1, M2, M3 and M4, respectively; and the cumulative oxidation state of transition metal ions a*(1-y-z-n)+(b*y)+(c*z)+(d*n) is equal to 4-x; and wherein said sodium layered oxide of formula I is not P2- Na2/3Ni1/4Mn1/2Ti1/6Zn1/12O2, P2-Na2/3Ni1/4Mn1/2Ti1/6Mg1/12O2, or P2-Na2/3Ni1/4Mn1/2Ti1/6Mg1/12O2.
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (France)
ECOLE NORMALE SUPERIEURE (France)
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (France)
COLLEGE DE FRANCE (France)
Inventor
Sagan, Sandrine
Joliot, Alain
Walrant, Astrid
Carlier, Ludovic
Cardon, Sébastien
Abstract
The present invention relates to a polypeptide X1X2-RK-X3X4-KK-X5X6X7X8X9X10-KR-X11X12 SEQ ID NO: 1 able to bind selectively to cells expressing proteoglycans comprising glycosaminoglycans as heparin or heparan sulfate. The linkage of said polypeptide to an internalization peptide enables the polypeptide to be internalized.
The present invention relates to a polypeptide X1X2-RK-X3X4-KK-X5X6X7X8X9X10-KR-X11X12 SEQ ID NO: 1 able to bind selectively to cells expressing proteoglycans comprising glycosaminoglycans as heparin or heparan sulfate. The linkage of said polypeptide to an internalization peptide enables the polypeptide to be internalized.
The present invention further relates to a conjugated polypeptide comprising said polypeptide and a biomarker, to a cell penetrating polypeptide comprising said polypeptide, optionally a linker and a cell internalization peptide and a chimeric polypeptide comprising said cell penetrating polypeptide and one or more biological cargos.
G01N 33/574 - ImmunoassayBiospecific binding assayMaterials therefor for cancer
C07K 14/47 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from animalsPeptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from humans from vertebrates from mammals
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (France)
COLLÈGE DE FRANCE (France)
UNIVERSITÉ DE LILLE (France)
UNIVERSITÉ POLYTECHNIQUE HAUTS-DE-FRANCE (France)
CENTRALE LILLE INSTITUT (France)
Inventor
Ouspenski, Vladimir
Assat, Gaurav
Tarascon, Jean-Marie
Koc, Tunkay
Lethien, Christophe
Hallot, Maxime
Abstract
The present invention relates to an all-solid-state-battery (ASSB) comprising an anode comprising a first solid electrolyte, a cathode composite comprising a second solid electrolyte, a solid electrolyte chosen from the group consisting in the first and the second solid electrolyte, and at least one buffer layer, in contact with a surface of the solid electrolyte, wherein when the solid electrolyte is the first solid electrolyte, one buffer layer is at the interface of said electrolyte with the cathode, and when the solid electrolyte is the second solid electrolyte, one buffer layer is at the interface of said electrolyte with the anode, wherein the first electrolyte is chosen from a sulphide solid electrolyte and a lithium oxide solid electrolyte, wherein the second electrolyte is a halide solid electrolyte, and wherein the buffer layer has a thickness ranging from 0.5 to less than 10 nm. The invention further pertains to an anode assembly, a cathode assembly and an electrolyte assembly comprising at least one buffer layer. The invention also relates to a process for making an ASSB or an assembly according to the invention wherein the buffer layer is deposited by a vapor deposition based method.
H01M 4/525 - Selection of substances as active materials, active masses, active liquids of inorganic oxides or hydroxides of nickel, cobalt or iron of mixed oxides or hydroxides containing iron, cobalt or nickel for inserting or intercalating light metals, e.g. LiNiO2, LiCoO2 or LiCoOxFy
H01M 4/62 - Selection of inactive substances as ingredients for active masses, e.g. binders, fillers
H01M 10/0525 - Rocking-chair batteries, i.e. batteries with lithium insertion or intercalation in both electrodesLithium-ion batteries
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (France)
COLLEGE DE FRANCE (France)
SORBONNE UNIVERSITE (France)
Inventor
Blangero, Maxime
Cabelguen, Pierre-Etienne
Tarascon, Jean-Marie
Li, Biao
Abstract
The present invention relates to Ni-rich Li-rich positive electrode active material doped with high-valence transition metal ions, such as Mo, exhibiting high capacity and excellent cycling stability.
H01M 4/525 - Selection of substances as active materials, active masses, active liquids of inorganic oxides or hydroxides of nickel, cobalt or iron of mixed oxides or hydroxides containing iron, cobalt or nickel for inserting or intercalating light metals, e.g. LiNiO2, LiCoO2 or LiCoOxFy
H01M 10/0525 - Rocking-chair batteries, i.e. batteries with lithium insertion or intercalation in both electrodesLithium-ion batteries
H01M 4/131 - Electrodes based on mixed oxides or hydroxides, or on mixtures of oxides or hydroxides, e.g. LiCoOx
H01M 4/36 - Selection of substances as active materials, active masses, active liquids
H01M 4/485 - Selection of substances as active materials, active masses, active liquids of inorganic oxides or hydroxides of mixed oxides or hydroxides for inserting or intercalating light metals, e.g. LiTi2O4 or LiTi2OxFy
H01M 4/505 - Selection of substances as active materials, active masses, active liquids of inorganic oxides or hydroxides of manganese of mixed oxides or hydroxides containing manganese for inserting or intercalating light metals, e.g. LiMn2O4 or LiMn2OxFy
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (France)
COLLEGE DE FRANCE (France)
SORBONNE UNIVERSITE (France)
Inventor
Blangero, Maxime
Cabelguen, Pierre-Etienne
Tarascon, Jean-Marie
Li, Biao
Abstract
The present invention relates to Li-rich positive electrode active material comprising a layered structure and a disordered rock-salt structure exhibiting high capacity and excellent cycling stability.
H01M 4/525 - Selection of substances as active materials, active masses, active liquids of inorganic oxides or hydroxides of nickel, cobalt or iron of mixed oxides or hydroxides containing iron, cobalt or nickel for inserting or intercalating light metals, e.g. LiNiO2, LiCoO2 or LiCoOxFy
H01M 10/0525 - Rocking-chair batteries, i.e. batteries with lithium insertion or intercalation in both electrodesLithium-ion batteries
H01M 4/02 - Electrodes composed of, or comprising, active material
23.
Voltage source and method for calibrating this voltage source
H03K 19/195 - Logic circuits, i.e. having at least two inputs acting on one outputInverting circuits using specified components using superconductive devices
G01R 33/035 - Measuring direction or magnitude of magnetic fields or magnetic flux using superconductive devices
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (France)
COLLEGE DE FRANCE (France)
ECOLE NORMALE SUPERIEURE DE PARIS (France)
SORBONNE UNIVERSITE (France)
Inventor
Barbosa De Aguiar, Hilton
Bruschini, Claudio
Charbon, Edoardo
Burri, Samuel
Abstract
The invention relates to an apparatus (100) for detecting one or more chemicals in a sample, the apparatus comprising: a scanning unit (104) comprising a light source configured to scan the sample using a light beam (112) having a linear-shaped illumination; a dispersive element (120) configured to receive light from the sample and disperse the received light spatially in a parallel manner; a spatial light modulator (122) configured to receive the dispersed light and select one or more wavelength bands of the dispersed light; and a detection unit (124) comprising a one-dimensional array of detectors configured to receive the selected one or more wavelength bands and detect the one or more chemicals in the sample based on the selected one or more wavelength bands, each detector of the array of detectors being a photon detector having a detection surface having a dimension below 50 pm, the dimension being in a direction of the linear-shaped illumination.
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (France)
SORBONNE UNIVERSITE (France)
COLLEGE DE FRANCE (France)
Inventor
Dugas, Romain
Tarascon, Jean-Marie
Abstract
An electrochemical cell, includes a positive electrode and a negative electrode arranged face to face in the cell body, and a stack of electrolyte layers interposed between the positive electrode and the negative electrode. The stack of electrolyte layers comprises a first layer of solid electrolyte arranged at one end of the positive electrode, a second layer of solid electrolyte arranged at one end of the negative electrode, a composite powder layer interposed between the first layer and the second layer, the composite powder layer comprising an electrolyte powder and an electroactive material powder serving as a reference electrode for the electrochemical cell.
H01M 50/569 - Constructional details of current conducting connections for detecting conditions inside cells or batteries, e.g. details of voltage sensing terminals
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (France)
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (France)
COLLEGE DE FRANCE (France)
Inventor
Balavoine, Fabrice
Llorens-Cortes, Catherine
Marc, Yannick
Abstract
The present invention relates to a pharmaceutical combination comprising (i) firibastat, (ii) a diuretic and (iii) a blocker of the systemic renin-angiotensin system selected from the group consisting of angiotensin I converting enzyme inhibitors (ACEIs) and angiotensin II receptor type 1 (AT1R) antagonists. Said composition is particularly useful for the treatment of hypertension and related diseases and conditions.
A61K 31/145 - Amines, e.g. amantadine having sulfur atoms, e.g. thiurams (N—C(S)—S—C(S)—N or N—C(S)—S—S—C(S)—N)Sulfinylamines (—N=SO)Sulfonylamines (—N=SO2)
A61K 31/549 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and at least one sulfur as the ring hetero atoms, e.g. sulthiame having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide
A61K 31/401 - ProlineDerivatives thereof, e.g. captopril
A61K 31/41 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole
The invention relates to a process for electrolysing carbon oxides selected from carbon monoxide and/or carbon dioxide into ethylene by means of an electrolyser comprising a cathode catalyst being a dendritic copper oxide catalyst or a dendritic copper catalyst.
C25B 9/23 - Cells comprising dimensionally-stable non-movable electrodesAssemblies of constructional parts thereof with diaphragms comprising ion-exchange membranes in or on which electrode material is embedded
C25B 9/77 - Assemblies comprising two or more cells of the filter-press type having diaphragms
C25B 11/075 - Electrodes formed of electrocatalysts on a substrate or carrier characterised by the electrocatalysts material consisting of a single catalytic element or catalytic compound
C25B 11/077 - Electrodes formed of electrocatalysts on a substrate or carrier characterised by the electrocatalysts material consisting of a single catalytic element or catalytic compound the compound being a non-noble metal oxide
A device is provided that measures an overall generated heat flow rate released by a battery cell The device comprises
an electrical power source for charging and discharging the battery,
an internal temperature sensor placed inside the battery,
a surface temperature sensor placed on the surface of the battery cell, and
an ambient temperature sensor placed in the ambient environment.
A device is provided that measures an overall generated heat flow rate released by a battery cell The device comprises
an electrical power source for charging and discharging the battery,
an internal temperature sensor placed inside the battery,
a surface temperature sensor placed on the surface of the battery cell, and
an ambient temperature sensor placed in the ambient environment.
The device also includes a memory that records the temperatures, and
a processor.
A device is provided that measures an overall generated heat flow rate released by a battery cell The device comprises
an electrical power source for charging and discharging the battery,
an internal temperature sensor placed inside the battery,
a surface temperature sensor placed on the surface of the battery cell, and
an ambient temperature sensor placed in the ambient environment.
The device also includes a memory that records the temperatures, and
a processor.
The processor computes characteristic thermal attributes of the battery cell based on a predetermined thermal equivalent circuit of the battery, using temperatures recorded over a predetermined calibration time period, during which the battery is subjected to current emitted by the electrical power source.
A device is provided that measures an overall generated heat flow rate released by a battery cell The device comprises
an electrical power source for charging and discharging the battery,
an internal temperature sensor placed inside the battery,
a surface temperature sensor placed on the surface of the battery cell, and
an ambient temperature sensor placed in the ambient environment.
The device also includes a memory that records the temperatures, and
a processor.
The processor computes characteristic thermal attributes of the battery cell based on a predetermined thermal equivalent circuit of the battery, using temperatures recorded over a predetermined calibration time period, during which the battery is subjected to current emitted by the electrical power source.
The processor then computes the heat flow rate generated by the battery cell towards its ambient environment from a set of recorded temperatures and the thermal attributes of the battery cell.
The invention relates to a method for in-life testing of the formation of the solid electrolyte interface layer of a battery cell, comprising the following steps:
sensing the temperature within the battery cell,
recording a first set of temperature (T) and/or pressure data related to the temperature variation (ΔT) and/or pressure variation within the battery cell over a first charge of the battery cell, and
determining a positive or negative datum relating to the formation of solid electrolyte interface layer of the battery cell according to said first set of temperature and/or pressure data
H01M 10/42 - Methods or arrangements for servicing or maintenance of secondary cells or secondary half-cells
G01K 11/3206 - Measuring temperature based on physical or chemical changes not covered by group , , , or using changes in transmittance, scattering or luminescence in optical fibres at discrete locations in the fibre, e.g. using Bragg scattering
G01L 11/02 - Measuring steady or quasi-steady pressure of a fluid or a fluent solid material by means not provided for in group or by optical means
30.
METHOD FOR QUALIFYING BATTERY QUALITY VIA OPERANDO HEAT FLOW RATE SENSING
A method for selecting between a first battery cell and a second battery cells includes sensing a total generated heat flow rate emitted by the first battery cell and the second battery cells. The method further includes recording, for the first and second battery cells, first and second sets of heat flow rate data related to the total generated heat flow rate emitted by the first and second battery cells, respectively, over their first charge. The method further includes comparing the first set of heat flow rate data with the second set of heat flow rate data, and selecting one of the first or second battery cells according to the comparison between the first set of heat flow rate data with the second set of heat flow rate data.
G01K 11/3206 - Measuring temperature based on physical or chemical changes not covered by group , , , or using changes in transmittance, scattering or luminescence in optical fibres at discrete locations in the fibre, e.g. using Bragg scattering
H01M 10/48 - Accumulators combined with arrangements for measuring, testing or indicating the condition of cells, e.g. the level or density of the electrolyte
31.
AN OXYGEN EVOLUTION REACTION ELECTRODE CATALYST ASSEMBLY COMPRISING DENDRITIC NICKEL FOAM, ITS USE AND A METHOD TO PRODUCE SAID ASSEMBLY
The present disclosure relates to a method to produce an oxygen evolution reaction electrode catalyst assembly comprising a dendritic nickel foam. The method is remarkable in that it comprises the steps of (a) providing a dendritic nickel foam material; (b) etching the dendritic nickel foam material by placing it in a etch solution being an acidic aqueous solution or an aqueous solution of metal chloride and recovering an etched dendritic nickel foam with nickel dendrites showing a chimney-like structure.
The disclosure relates to a gas diffusion electrode - GDE - suitable for carbon dioxide electrolysis, said gas diffusion electrode having a gas diffusion membrane, the gas diffusion electrode further comprising an ink (19) deposited on the gas diffusion membrane; wherein the ink comprises an ion-conducting polymer and copper nanoparticles functionalized with one or more pyridine-containing ligands, wherein the one or more pyridine-containing ligands have an anchoring group comprising one sulphur atom tethered to the copper nanoparticles. The disclosure also relates to a gas-fed flow cell comprising such gas diffusion electrode and to a method for producing such GDE as well to the electrolysis of carbon dioxide using such GDE.
C25B 11/095 - Electrodes formed of electrocatalysts on a substrate or carrier characterised by the electrocatalysts material consisting of at least one catalytic element and at least one catalytic compoundElectrodes formed of electrocatalysts on a substrate or carrier characterised by the electrocatalysts material consisting of two or more catalytic elements or catalytic compounds at least one of the compounds being organic
33.
MATERIALS FOR TERAHERTZ AND MILLIMETRIC WAVE ABSORPTION
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (France)
COLLEGE DE FRANCE (France)
UNIVERSITE DE LILLE (France)
CENTRALE LILLE INSTITUT (France)
UNIVERSITE POLYTECHNIQUE HAUTS DE FRANCE (France)
Inventor
Carenco, Sophie
Frogneux-Ple, Xavier
Sanchez, Clément
Hourlier, Djamila
Lampin, Jean-François
Abstract
The present disclosure relates to the field of materials capable of absorbing terahertz and millimetric waves. In particular, the present invention relates to a method for preparing a composite material consisting of a polysiloxane and graphite polymer lattice, as well as the composite material obtained by such a method and the ceramics obtainable from such a composite material.
C04B 35/571 - Fine ceramics obtained from polymer precursors
C04B 35/56 - Shaped ceramic products characterised by their compositionCeramic compositionsProcessing powders of inorganic compounds preparatory to the manufacturing of ceramic products based on non-oxides based on carbides
34.
METHOD FOR OPERANDO CHARACTERIZATION OF CHEMICAL SPECIES WITHIN A BATTERY USING INFRARED EVANESCENT WAVE SPECTROSCOPY
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (France)
COLLÈGE DE FRANCE (France)
SORBONNE UNIVERSITÉ (France)
UNIVERSITÉ DE RENNES 1 (France)
ECOLE NATIONALE SUPERIEURE DE CHIMIE DE RENNES (France)
INSTITUT NATIONAL DES SCIENCES APPLIQUEES DE RENNES (France)
Inventor
Tarascon, Jean-Marie
Gervillie, Charlotte
Boussard, Catherine
Zhang, Xiang-Hua
Adam, Jean-Luc
Abstract
Method for operando characterization of the chemical composition of a battery cell (12), comprising the following steps: - inserting an optical fiber (14) made of chalcogenide glass through the battery cell (12), - cycling the battery (12), - while cycling the battery (12), generating an optical signal and transmitting it through the optical fiber (14), - detecting, using an infrared spectrometer (20), the transmitted optical signal at an output extremity (14O) of the optical fiber (14), - recording the detected optical signal over time, - locating, using fiber evanescent wave spectroscopy, signature wavelengths for which the optical signal intensity is above a predetermined threshold within the spectrum, - associating said located signature wavelengths to at least one predetermined chemical species.
G01N 21/27 - ColourSpectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands using photo-electric detection
G01N 21/3577 - Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light for analysing liquids, e.g. polluted water
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (France)
COLLÉGE DE FRANCE (France)
SORBONNE UNIVERSITÉ (France)
Inventor
Tarascon, Jean-Marie
Marchini, Florencia
Abstract
The present invention generally relates to the use of a transition metal sulphide compound in a positive electrode for solid state batteries, to a transition metal sulphide compound, to a device or a material incorporating said compound, such as a composite material, an electrode, an electrochemical energy storage cell or a device such as an all-solid-state battery. It further relates to a method to manufacture and/or to use such a compound, material or device and to a process to manufacture said compound, material and/or device.
H01M 4/58 - Selection of substances as active materials, active masses, active liquids of inorganic compounds other than oxides or hydroxides, e.g. sulfides, selenides, tellurides, halogenides or LiCoFySelection of substances as active materials, active masses, active liquids of polyanionic structures, e.g. phosphates, silicates or borates
H01M 10/0525 - Rocking-chair batteries, i.e. batteries with lithium insertion or intercalation in both electrodesLithium-ion batteries
H01M 4/505 - Selection of substances as active materials, active masses, active liquids of inorganic oxides or hydroxides of manganese of mixed oxides or hydroxides containing manganese for inserting or intercalating light metals, e.g. LiMn2O4 or LiMn2OxFy
H01M 4/525 - Selection of substances as active materials, active masses, active liquids of inorganic oxides or hydroxides of nickel, cobalt or iron of mixed oxides or hydroxides containing iron, cobalt or nickel for inserting or intercalating light metals, e.g. LiNiO2, LiCoO2 or LiCoOxFy
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (France)
COLLÈGE DE FRANCE (France)
SORBONNE UNIVERSITÉ (France)
Inventor
Mariyappan, Sathiya
Tarascon, Jean-Marie
Hijazi, Hussein
Abstract
The invention relates to an electrolyte composition comprising at least one sodium salt dissolved in a solvent and a combination of additives, wherein: - said solvent comprises at least one compound selected from the group consisting of ethylene carbonate, dimethyl carbonate, ethyl methyl carbonate, diethyl carbonate, propylene carbonate, a carboxylate ester such as methyl acetate, ethyl acetate, ethyl propionate and methyl propionate, 4-fluorotoluene, 1,1,2,2-tetrafluoroethyl 2,2,3,3-tetrafluoropropyl ether, di-fluoro ethylene carbonate, ethyl difluoroacetate and diglyme, and - the combination of additives comprises at least tris(trimethylsilyl)phosphite (TMSPi) and succinonitrile (SN). The invention also relates to the use of the said electrolyte composition in a Na-ion battery, and a Na-ion battery comprising the same.
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (France)
COLLEGE DE FRANCE (France)
SORBONNE UNIVERSITE (France)
Inventor
Tarascon, Jean-Marie
Mariyappan, Sathiya
Marchandier, Thomas
Abstract
A compound of formula I: NaxNi0.5-yZnyMn0.5-zTizO2 (I), wherein x is a number ranging from 0.7 and 1.1, y is a number superior to 0 and up to 0.1, and z is a number between 0 and 0.5, batteries incorporating the compound and its use in particular as an positive electrode material for Na-ion batteries and cells and a process to obtain such a compound.
H01M 4/505 - Selection of substances as active materials, active masses, active liquids of inorganic oxides or hydroxides of manganese of mixed oxides or hydroxides containing manganese for inserting or intercalating light metals, e.g. LiMn2O4 or LiMn2OxFy
H01M 10/054 - Accumulators with insertion or intercalation of metals other than lithium, e.g. with magnesium or aluminium
H01M 4/525 - Selection of substances as active materials, active masses, active liquids of inorganic oxides or hydroxides of nickel, cobalt or iron of mixed oxides or hydroxides containing iron, cobalt or nickel for inserting or intercalating light metals, e.g. LiNiO2, LiCoO2 or LiCoOxFy
The disclosure relates to an OER electrode catalyst assembly comprising a multi-metallic catalyst and a support with the catalyst being deposited on the support, the catalyst comprising one or more iron oxides, the catalyst assembly is remarkable in that the support comprises dendritic nickel foam. A method for producing such catalyst assembly and a process for generating molecular oxygen by an oxygen evolution reaction using such catalyst assembly are also described.
C25B 11/077 - Electrodes formed of electrocatalysts on a substrate or carrier characterised by the electrocatalysts material consisting of a single catalytic element or catalytic compound the compound being a non-noble metal oxide
C25B 11/054 - Electrodes comprising electrocatalysts supported on a carrier
C25D 3/12 - ElectroplatingBaths therefor from solutions of nickel or cobalt
C25D 5/00 - Electroplating characterised by the processPretreatment or after-treatment of workpieces
C25B 11/091 - Electrodes formed of electrocatalysts on a substrate or carrier characterised by the electrocatalysts material consisting of at least one catalytic element and at least one catalytic compoundElectrodes formed of electrocatalysts on a substrate or carrier characterised by the electrocatalysts material consisting of two or more catalytic elements or catalytic compounds
39.
POLYPEPTIDES BINDING SELECTIVELY HEPARIN OR HEPARAN SULFATE GLYCOSAMINOGLYCANS AND CELL-PENETRATING POLYPEPTIDES COMPRISING THE SAME
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (France)
ECOLE NORMALE SUPERIEURE (France)
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (France)
COLLEGE DE FRANCE (France)
Inventor
Sagan, Sandrine
Joliot, Alain
Walrant, Astrid
Carlier, Ludovic
Cardon, Sébastien
Abstract
12345678910111212 (SEQ ID N°1) able to bind selectively to cells expressing proteoglycans comprising glycosaminoglycans as heparin or heparan sulfate. The linkage of said polypeptide to an internalization peptide enables the polypeptide to be internalized. The present invention further relates to a conjugated polypeptide comprising said polypeptide and a biomarker, to a cell penetrating polypeptide comprising said polypeptide, optionally a linker and a cell internalization peptide and a chimeric polypeptide comprising said cell penetrating polypeptide and one or more biological cargos.
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (France)
SORBONNE UNIVERSITE (France)
COLLEGE DE FRANCE (France)
Inventor
Fontecave, Marc
Mougel, Victor
Tran Ngoc, Huan
Alves Dalla Corte, Daniel
Lamaison, Sarah
Lutz, Lukas
Abstract
The present invention relates to an electrolysis device comprising an anode and a cathode, wherein the anode and the cathode each are an electrode comprising an electrically conductive support of which at least a part of the surface is covered by a metal deposit of copper, wherein the surface of the metal deposit is in an oxidized, sulfurated, selenated and/or tellurized form and the metal deposit has a specific surface area greater than or equal to 1 m2/g. The present invention relates also to a method for reducing CO2 into hydrocarbons using an electrolysis device according to the invention. The method according to the invention comprises: a) providing an electrolysis device according to the invention; b) exposing the cathode of said electrolysis device to a CO2-containing aqueous catholyte solution; c) exposing the anode of said electrolysis device to an aqueous anolyte solution; and d) applying an electrical current between the anode and the cathode in order to reduce the carbon dioxide into hydrocarbons.
C25B 11/077 - Electrodes formed of electrocatalysts on a substrate or carrier characterised by the electrocatalysts material consisting of a single catalytic element or catalytic compound the compound being a non-noble metal oxide
CENTRE NATIONAL DE LA RECHERECHE SCIENTIFIQUE (France)
Inventor
Fontecave, Marc
Mougel, Victor
Wakerley, David
Lamaison, Sarah
Abstract
Disclosed are surface modified electrodes, their process of preparation and their use in the electrolytic reduction of carbon dioxide and/or carbon monoxide, as well as an electrochemical cell including the electrode.
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (France)
COLLEGE DE FRANCE (France)
Inventor
Girit, Caglar
Smirr, Jean-Loup
Abstract
The invention relates to an electrical voltage source (1) comprising - an integrated circuit (2) comprising two input terminals configured to receive an electrical control signal, two output terminals configured to deliver an output voltage (Vs), at least one Josephson junction which is coupled to the input terminals and to the output terminals such that the value of the output voltage (Vs) depends on the frequency of the electrical control signal (6), - a cryogenic module (3), - a microwave generator (4) configured to deliver the electrical control signal (6). The source of electrical voltage (1) comprises an adjustment module (5) configured to adjust the amplitude of the electrical control signal (6) as a function of its frequency according to a predetermined rule. The invention further relates to a method for calibrating such a source.
G05F 3/16 - Regulating voltage or current wherein the variable is DC using uncontrolled devices with non-linear characteristics being semiconductor devices
43.
Method for Converting Carbon Dioxide (CO2) into Syngas by an Electrolysis Reaction
The present invention relates to a method for CO2 electroreduction to syngas, a mixture of carbon monoxide (CO) and hydrogen (H2), using a cathode comprising an electrically conductive support of which at least a part of the surface is covered by a metal deposit of zinc and of a second metal selected from copper, gold and mixtures thereof, and being preferably copper, said metal deposit comprising at least 1 wt % of one or several phases of an alloy of zinc and of the second metal.
The present invention relates to a method for CO2 electroreduction to syngas, a mixture of carbon monoxide (CO) and hydrogen (H2), using a cathode comprising an electrically conductive support of which at least a part of the surface is covered by a metal deposit of zinc and of a second metal selected from copper, gold and mixtures thereof, and being preferably copper, said metal deposit comprising at least 1 wt % of one or several phases of an alloy of zinc and of the second metal.
The present invention relates also to an electrode useful for performing this method, a process for preparing such an electrode and an electrolysis device comprising such an electrode.
C25B 11/091 - Electrodes formed of electrocatalysts on a substrate or carrier characterised by the electrocatalysts material consisting of at least one catalytic element and at least one catalytic compoundElectrodes formed of electrocatalysts on a substrate or carrier characterised by the electrocatalysts material consisting of two or more catalytic elements or catalytic compounds
C25B 11/054 - Electrodes comprising electrocatalysts supported on a carrier
C25B 9/23 - Cells comprising dimensionally-stable non-movable electrodesAssemblies of constructional parts thereof with diaphragms comprising ion-exchange membranes in or on which electrode material is embedded
44.
Method for Converting Carbon Dioxide (CO2) into CO by an Electrolysis Reaction
The present invention relates to an electrode comprising a metal deposit of zinc and silver, a process for preparing such an electrode, an electrolysis device comprising such an electrode and a method for CO2 electroreduction to CO using such an electrode as a cathode.
C25B 11/081 - Electrodes formed of electrocatalysts on a substrate or carrier characterised by the electrocatalysts material consisting of a single catalytic element or catalytic compound the element being a noble metal
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (France)
SORBONNE UNIVERSITE (France)
COLLEGE DE FRANCE (France)
ECOLE NORMALE SUPERIEURE (France)
Inventor
Lescanne, Raphaël
Deleglise, Samuel
Flurin, Emmanuel
Leghtas, Zaki
Abstract
A superconducting detection device for detecting a single microwave photon, including: —a quantum system with two energy levels of which the ground state and an excited state are controllable and detectable, the quantum system being designed to allow modulable three-wave interaction; —a buffer resonator arranged to receive an incident single microwave photon; —a highly dissipative auxiliary resonator arranged to discharge a photon; and —a reading device arranged to detect the state of the two-level quantum system; the buffer resonator and the auxiliary resonator are coupled to the quantum system; and the excited state of the quantum system and the photon of the auxiliary resonator are created in response to the reception of the incident photon in the buffer resonator and to the application of parametric pumping to the device. A method for detecting a single microwave photon implemented by a device according to the invention.
INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE (France)
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (France)
COLLEGE DE FRANCE (France)
Inventor
Balavoine, Fabrice
Compere, Delphine
Keck, Mathilde
Marc, Yannick
Llorens-Cortes, Catherine
Boitard, Solène E.
Abstract
The present invention relates to compounds, to compositions comprising the same, to methods for preparing the compounds, and the use of these compounds in therapy. In particular, the present invention relates to a compound that is useful in the treatment and prevention of primary and secondary arterial hypertension, ictus, myocardial ischaemia, cardiac and renal insufficiency, myocardial infarction, peripheral vascular disease, diabetic proteinuria, Syndrome X and glaucoma.
C07C 323/58 - Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (France)
SORBONNE UNIVERSITE (France)
COLLEGE DE FRANCE (France)
Inventor
Dugas, Romain
Tarascon, Jean-Marie
Abstract
The invention relates to an electrochemical cell (1), comprising a positive electrode (11) and a negative electrode (12) disposed face to face in the cell body (10), and a stack of electrolytic layers (13, 14, 15) interposed between the positive electrode (11) and the negative electrode (12). The stack of electrolytic layers (13, 14, 15) comprises a first solid electrolyte layer (13) disposed at one end of the positive electrode (11), a second solid electrolyte layer (14) disposed at one end of the negative electrode (12), a layer of composite powder (15) interposed between the first (13) and the second layer (14), the layer of composite powder (15) comprising an electrolyte powder and a powder of electroactive material functioning as a reference electrode of the electrochemical cell.
H01M 10/0585 - Construction or manufacture of accumulators having only flat construction elements, i.e. flat positive electrodes, flat negative electrodes and flat separators
H01M 10/48 - Accumulators combined with arrangements for measuring, testing or indicating the condition of cells, e.g. the level or density of the electrolyte
G01R 31/00 - Arrangements for testing electric propertiesArrangements for locating electric faultsArrangements for electrical testing characterised by what is being tested not provided for elsewhere
48.
HOMEOPROTEINS FOR USE IN THE TREATMENT OF NEURODEGENERATIVE DISORDERS
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (France)
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (France)
COLLEGE DE FRANCE (France)
SORBONNE UNIVERSITE (France)
Inventor
Prochiantz, Alain
Abstract
The present disclosure relates to the use of a homeoprotein or a recombinant vector encoding said protein for treating or preventing DNA damage and/or cellular aging. In particular, the invention concerns the use of Engrailed for the treatment of Parkinson disease.
A61K 38/17 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from animalsPeptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from humans
A61P 25/28 - Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE) (France)
COMMISSARIAT À L'ÉNERGIE ATOMIQUE ET AUX ÉNERGIES ALTERNATIVES (CEA) (France)
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (France)
COLLEGE DE FRANCE (France)
ASSISTANCE PUBLIQUE-HÔPITAUX DE PARIS (APHP) (France)
UNIVERSITÉ DE PARIS (France)
UNIVERSITÉ PARIS-SACLAY (France)
Inventor
De The, Hugues
Renou, Laurent
Pflumio, Françoise
Lallemand-Breitenbach, Valérie
Naguibneva, Irina
Ballerini, Paola
Haddad, Rima
Abstract
The present invention relates to a method for treating a cancer having a protein kinase gene fused to a gene coding for a nuclear-envelop protein or a protein interacting with the nuclear envelop in a subject comprising administering to the subject a therapeutically effective of an arsenic compound, an inductor of type 1 IFNs and a tyrosine kinase inhibitor (TKI), as combined preparation. Indeed, inventors have validated the present invention with in vivo and in vitro models. Treatments started in mice with leukemic burden being >3% (up to 90%) hCD45+CD7+ cells in the blood as detected by flow cytometry in individual tested mice. DASA (20mg/Kg, diluted in 80mM citric acid, pH2.1) was delivered using per os administration. ATO (5mg/Kg, diluted in TBS, pH7) and PolyI:PolyC (PIPC, 20mg/Kg diluted in PBS, SIGMA) were injected using intraperitoneal route. The time scale of drug delivery is indicated for every experiment performed. Mice were weighed every day of treatments, in order to ensure they were not losing too much weight and also to adjust the delivered drug doses. DASA+ATO+PIPC treated mice had a significantly prolonged survival compared to the other treatment conditions, showing major differences between results of treatment protocols. ATO combined with IFN-type 1 inducers and inhibitors of TK represents a powerful way for eradication of T-ALL cells that implicate high ABL1 activity and nuclear pore protein lesions.
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (France)
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (France)
COLLEGE DE FRANCE (France)
Inventor
Balavoine, Fabrice
Llorens-Cortes, Catherine
Marc, Yannick
Abstract
The present invention relates to a pharmaceutical combination comprising (i) firibastat, (ii) a diuretic and (iii) a blocker of the systemic renin-angiotensin system selected from the group consisting of angiotensin I converting enzyme inhibitors (ACEIs) and angiotensin II receptor type 1 (AT1R) antagonists. Said composition is particularly useful for the treatment of hypertension and related diseases and conditions.
A61K 31/41 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole
A61K 31/549 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and at least one sulfur as the ring hetero atoms, e.g. sulthiame having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide
A61K 31/185 - AcidsAnhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
A61K 31/255 - Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
A61K 31/401 - ProlineDerivatives thereof, e.g. captopril
A61K 31/403 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
A61K 31/405 - Indole-alkanecarboxylic acidsDerivatives thereof, e.g. tryptophan, indomethacin
A61K 31/4178 - 1,3-Diazoles not condensed and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
A61K 31/567 - Compounds containing cyclopenta[a]hydrophenanthrene ring systemsDerivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
The invention relates to a method for selecting between a first and a second battery cells, wherein it comprises the following steps : - sensing the total generated heat flow rate emitted by a first (10A) and second (10B) battery cells, - recording, for the first (10A) and second (10B) battery cells, first and second sets of heat flow rate data related to the total generated heat flow rate emitted by the first (10A) and second (10B) battery cells, respectively, over their first charge, - comparing the first set of heat flow rate data with the second set of heat flow rate data, and - selecting one of the first (10A) or second (10B) battery cells according to the comparison between the first set of heat flow rate data with the second set of heat flow rate data.
H01M 10/42 - Methods or arrangements for servicing or maintenance of secondary cells or secondary half-cells
H01M 10/48 - Accumulators combined with arrangements for measuring, testing or indicating the condition of cells, e.g. the level or density of the electrolyte
INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE (France)
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (France)
COLLEGE DE FRANCE (France)
Inventor
Balavoine, Fabrice
Compere, Delphine
Llorens-Cortes, Catherine
Marc, Yannick
Abstract
The present invention relates to a novel compound, to a composition comprising the same, to methods for preparing the compound, and the use of this compound in therapy. In particular, the present invention relates to a compound that is useful in the treatment and prevention of primary and secondary arterial hypertension, ictus, myocardial ischaemia, cardiac and renal insufficiency, myocardial infarction, peripheral vascular disease, diabetic proteinuria, Syndrome X and glaucoma.
The invention relates to a method for in-life testing of the formation of the solid electrolyte interface layer of a battery cell, comprising the following steps : - sensing the temperature within the battery cell, - recording a first set of temperature (T) and/or pressure data related to the temperature variation (ΔΤ) and/or pressure variation within the battery cell over a first charge of the battery cell, and - determining a positive or negative datum relating to the formation of solid electrolyte interface layer of the battery cell according to said first set of temperature and/or pressure data.
H01M 10/48 - Accumulators combined with arrangements for measuring, testing or indicating the condition of cells, e.g. the level or density of the electrolyte
54.
CALORIMETER FOR IN OPERANDO MEASURING OF THE OVERALL HEAT RELEASED BY A BATTERY CELL
The invention concerns a device (12) for measuring the overall generated heat flow rate released by a battery cell (10), comprising: - an electrical power source for charging and discharging the battery, - an internal temperature sensor (16), placed inside the battery, - a surface temperature sensor (18), placed on the surface of the battery cell - an ambient temperature sensor (14), placed in the ambient environment, - a memory (22) for recording the temperatures, and - a processor (24). The processor (24) computes characteristic thermal attributes of the battery cell (10) based on a predetermined thermal equivalent circuit of the battery (10), using temperatures recorded over a predetermined calibration time period, during which the battery is subjected to current emitted by the electrical power source (20). The processor (22) then computes the heat flow rate generated by the battery cell (10) towards its ambient environment from a set of recorded temperatures and the thermal attributes of the battery cell (10).
G01K 7/42 - Circuits effecting compensation of thermal inertiaCircuits for predicting the stationary value of a temperature
G01K 11/32 - Measuring temperature based on physical or chemical changes not covered by group , , , or using changes in transmittance, scattering or luminescence in optical fibres
G01K 15/00 - Testing or calibrating of thermometers
H01M 10/48 - Accumulators combined with arrangements for measuring, testing or indicating the condition of cells, e.g. the level or density of the electrolyte
55.
Ligand controling interaction between gags with their effector molecules and use thereof
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (France)
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (France)
SORBONNE UNIVERSITE (France)
ECOLE NORMALE SUPERIEURE (France)
COLLEGE DE FRANCE (France)
Inventor
Mallet, Jean-Maurice
Lavielle, Solange
Marquant, Rodrigue
Prochiantz, Alain
Di Nardo, Ariel
Testa, Damien
Abstract
The invention relates to new compounds that mimic Glycosaminoglycans and are able to control interaction between Glycosaminoglycans with their effector molecules. The compounds of the invention are peptides and are able to prevent or reduce the binding of at least one effector molecule with at least one glycosaminoglycan. The compounds according to the invention can be used as drug, in particular for the stimulation of the neurogenesis and more generally to treat nervous system related pathologies.
A61K 38/04 - Peptides having up to 20 amino acids in a fully defined sequenceDerivatives thereof
C07K 14/47 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from animalsPeptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from humans from vertebrates from mammals
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (France)
Inventor
Vacquier, Christophe
Rovira, Nathalia
Baverel, Christophe
Laberty-Robert, Christel
Coustan, Laura
Sanchez, Clément
Abstract
The present application relates to a proton exchange membrane for fuel cell, said membrane having self-regenerating properties, to cells comprising said membranes, and to the manufacturing method thereof via electrospinning.
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (France)
COLLEGE DE FRANCE (France)
Inventor
Odziomek, Mateusz
Faustini, Marco
Boissiere, Cédric
Sanchez, Clément
Abstract
The invention relates to a method for forming at least one periodic array of cracks of an inorganic micropatterned coating, wherein each crack of said at least one periodic array of cracks extends over the substrate along an axis following a linear direction, each axis of each crack being parallel to the axis of the other cracks. The invention also relates to an inorganic micropatterned coating as defined, said coating being obtainable by the method of the invention. The invention also related to a device comprising an inorganic micropatterned coating of the invention, an ink composition for the production of an inorganic micropatterned coating of the invention and the use of said ink composition for obtaining an inorganic micropatterned coating of the invention.
C09D 5/28 - Coating compositions, e.g. paints, varnishes or lacquers, characterised by their physical nature or the effects producedFilling pastes for wrinkle, crackle, orange-peel, or similar decorative effects
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (France)
COLLEGE DE FRANCE (France)
SORBONNE UNIVERSITE (France)
Inventor
Wang, Qing
Tarascon, Jean-Marie
Chakir, Mohamed
Mariyappan, Sathiya
Abstract
The present invention relates to a positive electrode active material of the following formula (I): NaxLiyMnl-yO2 (I), where x is a number from 0.8 to 1; y is a number strictly greater than 0 and smaller than or equal to 1/3.
C01G 45/12 - Complex oxides containing manganese and at least one other metal element
H01M 4/505 - Selection of substances as active materials, active masses, active liquids of inorganic oxides or hydroxides of manganese of mixed oxides or hydroxides containing manganese for inserting or intercalating light metals, e.g. LiMn2O4 or LiMn2OxFy
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (France)
COLLEGE DE FRANCE (France)
SORBONNE UNIVERSITÉ (France)
Inventor
Tarascon, Jean-Marie
Yan, Guochun
Abstract
An electrolyte composition includes at least a sodium salt dissolved in at least one solvent and a combination of additives. The solvent is any of ethylene carbonate, dimethyl carbonate, ethyl methyl carbonate, diethyl carbonate, propylene carbonate, ethyl acetate, ethyl propionate, methyl propionate, 4-fluorotoluene, 1,1,2,2-tetrafluoroethyl 2,2,3,3-tetrafluoropropyl ether, di-fluoro ethylene carbonate, ethyl difluoroacetate, or mixtures of the foregoing. The combination of additives includes at least sodium difluoro(oxalato)borate (NaODFB) and tris(trimethylsilyl)phosphite (TMSPi).
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (France)
COLLÈGE DE FRANCE (France)
SORBONNE UNIVERSITÉ (France)
Inventor
Tarascon, Jean-Marie
Marchini, Florencia
Abstract
The present invention generally relates to the use of a transition metal sulphide compound in a positive electrode for solid state batteries, to a transition metal sulphide compound, to a device or a material incorporating said compound, such as a composite material, an electrode, an electrochemical energy storage cell or a device such as an all-solid-state battery. It further relates to a method to manufacture and/or to use such a compound, material or device and to a process to manufacture said compound, material and/or device.
H01M 4/36 - Selection of substances as active materials, active masses, active liquids
H01M 4/505 - Selection of substances as active materials, active masses, active liquids of inorganic oxides or hydroxides of manganese of mixed oxides or hydroxides containing manganese for inserting or intercalating light metals, e.g. LiMn2O4 or LiMn2OxFy
H01M 4/525 - Selection of substances as active materials, active masses, active liquids of inorganic oxides or hydroxides of nickel, cobalt or iron of mixed oxides or hydroxides containing iron, cobalt or nickel for inserting or intercalating light metals, e.g. LiNiO2, LiCoO2 or LiCoOxFy
H01M 4/58 - Selection of substances as active materials, active masses, active liquids of inorganic compounds other than oxides or hydroxides, e.g. sulfides, selenides, tellurides, halogenides or LiCoFySelection of substances as active materials, active masses, active liquids of polyanionic structures, e.g. phosphates, silicates or borates
LE CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (France)
COLLEGE DE FRANCE (France)
SPECIALTY OPERATIONS FRANCE (France)
Inventor
Tarascon, Jean-Marie
Ma, Jiwei
Bertry, Laure
Amisse, Robin
Braida, Marc-David
Le Mercier, Thierry
Buissette, Valérie
Abstract
The present invention relates to the new process of preparation of a Li-rich layered oxide based on Mn and optionally on Ni and/or Co in which F is incorporated within the crystal of the oxide (or “fluorinated oxide”). It also relates to the new fluorinated oxide its use as a component in a cathode of a battery.
H01M 4/505 - Selection of substances as active materials, active masses, active liquids of inorganic oxides or hydroxides of manganese of mixed oxides or hydroxides containing manganese for inserting or intercalating light metals, e.g. LiMn2O4 or LiMn2OxFy
C01G 45/12 - Complex oxides containing manganese and at least one other metal element
H01M 4/525 - Selection of substances as active materials, active masses, active liquids of inorganic oxides or hydroxides of nickel, cobalt or iron of mixed oxides or hydroxides containing iron, cobalt or nickel for inserting or intercalating light metals, e.g. LiNiO2, LiCoO2 or LiCoOxFy
H01M 4/62 - Selection of inactive substances as ingredients for active masses, e.g. binders, fillers
H01M 10/0525 - Rocking-chair batteries, i.e. batteries with lithium insertion or intercalation in both electrodesLithium-ion batteries
H01M 4/02 - Electrodes composed of, or comprising, active material
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (France)
COLLEGE DE FRANCE (France)
SORBONNE UNIVERSITE (France)
Inventor
Tarascon, Jean-Marie
Mariyappan, Sathiya
Marchandier, Thomas
Abstract
x0.5-yy0.5-zz2 2 (I), wherein x is a number ranging from 0.7 and 1.1, y is a number superior to 0 and up to 0.1, and z is a number between 0 and 0.5., batteries incorporating the compound and its use in particular as an positive electrode material for Na-ion batteries and cells and a process to obtain such a compound.
H01M 4/36 - Selection of substances as active materials, active masses, active liquids
H01M 4/525 - Selection of substances as active materials, active masses, active liquids of inorganic oxides or hydroxides of nickel, cobalt or iron of mixed oxides or hydroxides containing iron, cobalt or nickel for inserting or intercalating light metals, e.g. LiNiO2, LiCoO2 or LiCoOxFy
H01M 10/054 - Accumulators with insertion or intercalation of metals other than lithium, e.g. with magnesium or aluminium
63.
COMPOUNDS AND COMPOSITIONS COMPRISING THE SAME FOR TREATING HYPERTENSION OR HEART FAILURE
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (France)
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (France)
COLLEGE DE FRANCE (France)
Inventor
Balavoine, Fabrice
Compere, Delphine
Keck, Mathilde
Marc, Yannick
Llorens-Cortes, Catherine
Boitard, Solène E.
Abstract
The present invention relates to compounds, to compositions comprising the same, to methods for preparing the compounds, and the use of these compounds in therapy. In particular, the present invention relates to a compound that is useful in the treatment and prevention of primary and secondary arterial hypertension, ictus, myocardial ischaemia, cardiac and renal insufficiency, myocardial infarction, peripheral vascular disease, diabetic proteinuria, Syndrome X and glaucoma.
A61K 31/197 - Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
A61K 33/04 - Sulfur, selenium or telluriumCompounds thereof
A61P 9/04 - Inotropic agents, i.e. stimulants of cardiac contractionDrugs for heart failure
A61P 9/10 - Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
A61P 13/12 - Drugs for disorders of the urinary system of the kidneys
A61P 25/28 - Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (France)
Inventor
Coustan, Laura
Laberty-Robert, Christel
Tarascon, Jean-Marie
Abstract
The present invention relates to a battery separator comprising monophasic non- woven hybrid nanofibers, wherein: - said non-woven hybrid nanofibers comprise at least one metal oxide and at least one polymer chosen from the group consisting of fluoropolymers, vinylpolymers, polyethers, and mixtures thereof, and - said non-woven hybrid nanofibers have a diameter ranging from 20 to 1,000 nm.
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (France)
Inventor
Fontecave, Marc
Mougel, Victor
Wakerley, David
Lamaison, Sarah
Abstract
The present invention relates to surface modified electrodes, their process of preparation and their use in the electrolytic reduction of carbon dioxide and/or carbon monoxide, as well as an electrochemical cell comprising said electrode.
C25B 1/00 - Electrolytic production of inorganic compounds or non-metals
C25B 3/04 - Electrolytic production of organic compounds by reduction
C25B 11/03 - ElectrodesManufacture thereof not otherwise provided for characterised by shape or form perforated or foraminous
C25B 11/04 - ElectrodesManufacture thereof not otherwise provided for characterised by the material
66.
Electrolyte composition including a specific combination of additives, its use as non-aqueous liquid electrolyte in a Na-ion battery and Na-ion battery including such an electrolyte composition
Centre national de la recherche scientifique (France)
College de france (France)
Sorbonne Universite (France)
Inventor
Yan, Guochun
Tarascon, Jean-Marie
Abstract
Some embodiments include an electrolyte composition for a battery using sodium ions as electrochemical vector, to the use of such an electrolyte composition as non-aqueous liquid electrolyte in a sodium-ion battery and to a sodium-ion battery comprising such a non-aqueous liquid electrolyte. In some embodiments, the amount of (oxalato)borate ranges from 0.05 to 10 wt. %, relative to the total weight of the electrolyte composition.
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (France)
SORBONNE UNIVERSITE (France)
COLLEGE DE FRANCE (France)
ECOLE NORMALE SUPERIEURE (France)
Inventor
Lescanne, Raphaël
Deleglise, Samuel
Flurin, Emmanuel
Leghtas, Zaki
Abstract
The invention concerns a superconducting detection device (1) for detecting a single microwave photon (2), characterised in that the device (1) comprises: - a quantum system (10) with two energy levels of which the ground state and an excited state are controllable and detectable, the quantum system (10) being designed to allow modulable three-wave interaction; - a buffer resonator (12) arranged to receive an incident single microwave photon (2); - a highly dissipative auxiliary resonator (14) arranged to discharge a photon (3); and - reading means arranged to detect the state of the two-level quantum system (10); in which the buffer resonator (12) and the auxiliary resonator (14) are coupled to the quantum system (10); and in which the excited state of the quantum system (10) and the photon of the auxiliary resonator (14) are created in response to the reception of the incident photon in the buffer resonator (12) and to the application of parametric pumping (4) to the device (1). The invention also concerns a method for detecting a single microwave photon implemented by means of a device (1) according to the invention.
PARIS SCIENCES ET LETTRES - QUARTIER LATIN (France)
COLLEGE DE FRANCE (France)
Inventor
Fontecave, Marc
Mougel, Victor
Tran Ngoc, Huan
Wakerley, David
Lamaison, Sarah
Abstract
222 ),using a cathode comprisingan electrically conductive support of which at least a part of the surface is covered by a metal deposit of zinc and of a second metal selected from copper, gold and mixtures thereof, and being preferably copper, said metal deposit comprising at least 1 wt% of one or several phases of an alloy of zinc and of the second metal. The present invention relates also to an electrode useful for performing this method, a process for preparing such an electrode and an electrolysis device comprising such an electrode.
PARIS SCIENCES ET LETTRES - QUARTIER LATIN (France)
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (France)
SORBONNE UNIVERSITE (France)
COLLEGE DE FRANCE (France)
Inventor
Fontecave, Marc
Mougel, Victor
Tran Ngoc, Huan
Alves Dalla Corte, Daniel
Lamaison, Sarah
Lutz, Lukas
Abstract
The present invention relates to an electrolysis device comprising an anode and a cathode, wherein the anode and the cathode each are an electrode comprising an electrically conductive support of which at least a part of the surface is covered by a metal deposit of copper, wherein the surface of the metal deposit is in an oxidized, suIfurated, selenated and/or tellurized form and the metal deposit has a specific surface area greater than or equal to 1 m2222-containing aqueous catholyte solution; c) exposing the anode of said electrolysis device to an aqueous anolyte solution; and d) applying an electrical current between the anode and the cathode in order to reduce the carbon dioxide into hydrocarbons.
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (France)
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (France)
COLLEGE DE FRANCE (France)
Inventor
Balavoine, Fabrice
Compere, Delphine
Llorens-Cortes, Catherine
Marc, Yannick
Abstract
The present invention relates to a novel compound, to a composition comprising the same, to methods for preparing the compound, and the use of this compound in therapy. In particular, the present invention relates to compound that is useful in the treatment and prevention of primary and secondary arterial hypertension, ictus, myocardial ischaemia, cardiac and renal insufficiency, myocardial infarction, peripheral vascular disease, diabetic proteinuria, Syndrome X and glaucoma.
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (France)
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (France)
COLLEGE DE FRANCE (France)
Inventor
Balavoine, Fabrice
Compere, Delphine
Llorens-Cortes, Catherine
Abstract
The present invention relates to a novel compound, to a composition comprising the same, to methods for preparing the compound, and the use of this compound in therapy. In particular, the present invention relates to compound that is useful in the treatment and prevention of primary and secondary arterial hypertension, ictus, myocardial ischaemia, cardiac and renal insufficiency, myocardial infarction, peripheral vascular disease, diabetic proteinuria, Syndrome X and glaucoma.
A61K 31/662 - Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
A61P 9/10 - Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (France)
COLLEGE DE FRANCE (France)
SORBONNE UNIVERSITE (France)
Inventor
Chakir, Mohamed
Mariyappan, Sathiya
Tarascon, Jean-Marie
Wang, Qing
Abstract
x0.5-yy0.5-zz22 (I), in which: - x varies from 0.9 to 1; - y varies from 0.05 to 0.1; - z varies from 0.1 to 0.3, it being understood that, if z is equal to 0.1 and x is equal to 1, then y is not equal to 0.05.
−1 and a mesopore size ranging from 2 nm to 50 nm. Further, the use of a material having a high specific surface area for the absorption of pollutants species.
B01J 20/02 - Solid sorbent compositions or filter aid compositionsSorbents for chromatographyProcesses for preparing, regenerating or reactivating thereof comprising inorganic material
B01J 20/28 - Solid sorbent compositions or filter aid compositionsSorbents for chromatographyProcesses for preparing, regenerating or reactivating thereof characterised by their form or physical properties
B01J 20/30 - Processes for preparing, regenerating or reactivating
75.
LIGAND CONTROLING INTERACTION BETWEEN GAGS WITH THEIR EFFECTOR MOLECULES AND USE THEREOF
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (France)
SORBONNE UNIVERSITE (France)
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (France)
Inventor
Mallet, Jean-Maurice
Lavielle, Solange
Marquant, Rodrigue
Prochiantz, Alain
Di Nardo, Ariel
Testa, Damien
Abstract
The invention relates to new compounds that mimic Glycosaminoglycans and are able to control interaction between Glycosaminoglycans with their effector molecules. The compounds of the invention are peptides and are able to prevent or reduce the binding of at least one effector molecule with at least one glycosaminoglycan. The compounds according to the invention can be used as drug, in particular for the stimulation of the neurogenesis and more generally to treat nervous system related pathologies.
C07K 7/08 - Linear peptides containing only normal peptide links having 12 to 20 amino acids
C07K 14/00 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof
C07K 14/47 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from animalsPeptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from humans from vertebrates from mammals
A61K 38/04 - Peptides having up to 20 amino acids in a fully defined sequenceDerivatives thereof
76.
NEW ELECTROLYTE COMPOSITION FOR SODIUM-ION BATTERY
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (France)
COLLEGE DE FRANCE (France)
SORBONNE UNIVERSITÉ (France)
Inventor
Tarascon, Jean-Marie
Yan, Guochun
Abstract
The present invention relates to an electrolyte composition comprising at least a sodium salt dissolved in at least one solvent and a combination of additives, wherein: - said solvent is selected from the group consisting of: ethylene carbonate, dimethyl carbonate, ethyl methyl carbonate, diethyl carbonate, propylene carbonate, ethyl acetate, ethyl propionate, methyl propionate, 4-fluorotoluene, 1,1,2,2- tetrafluoroethyl 2,2,3,3-tetrafluoropropyl ether, di-fluoro ethylene carbonate, ethyl difluoroacetate, and mixtures thereof; - the combination of additives includes at least sodium difluoro(oxalato)borate (NaODFB) and tris(trimethylsilyl)phosphite (TMSPi).
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE—CNRS— (France)
COLLEGE DE FRANCE (France)
Inventor
Astorg, Adele
Crozes, Xavier
Nicole, Lionel
Sanchez, Clement
Abstract
A sol-gel method for producing an anti-corrosion coating consisting of at least one layer of an oxide on a metal substrate. A non-aqueous solution of a precursor of the oxide is prepared and deposited on one surface at least of the metal substrate in order to cover said surface at least partially with a film comprising the precursor of the oxide. Hydrolysis-condensation of the precursor of the oxide is carried out by exposing the film to a humid atmosphere in order to form an oxide network in the film. Then, a treatment for stabilizing the film on the surface of the substrate is carried out, followed by a heat treatment of the surface of the metal substrate in order to crystallize the network of oxide and form the anti-corrosion coating.
C23C 18/12 - Chemical coating by decomposition of either liquid compounds or solutions of the coating forming compounds, without leaving reaction products of surface material in the coatingContact plating by thermal decomposition characterised by the deposition of inorganic material other than metallic material
C23C 22/00 - Chemical surface treatment of metallic material by reaction of the surface with a reactive liquid, leaving reaction products of surface material in the coating, e.g. conversion coatings, passivation of metals
78.
NEW SODIUM-BASED MATERIAL AND ITS USE AS POSITIVE ELECTRODE MATERIAL OR NA-ION CELLS
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (France)
COLLEGE DE FRANCE (France)
UNIVERSITE DE PICARDIE JULES VERNE (France)
SORBONNE UNIVERSITÉ (France)
Inventor
Tarascon, Jean-Marie
Yan, Guochun
Mariyappan, Sathiya
David, Renald
Abstract
3-xx(2-y)423-zz/2z/2 (I) wherein: □ represents a vacancy; and M represents a transition or a non-transition metal ion. The present invention also relates to a method of preparation of the material of formula (I), its uses as a positive electrode material and a Na-ion cell comprising a positive electrode comprising said material of formula (I).
H01M 4/13915 - Processes of manufacture of electrodes based on mixed oxides or hydroxides, or on mixtures of oxides or hydroxides, e.g. LiCoOx containing halogen atoms, e.g. LiCoOxFy
H01M 4/58 - Selection of substances as active materials, active masses, active liquids of inorganic compounds other than oxides or hydroxides, e.g. sulfides, selenides, tellurides, halogenides or LiCoFySelection of substances as active materials, active masses, active liquids of polyanionic structures, e.g. phosphates, silicates or borates
H01M 10/05 - Accumulators with non-aqueous electrolyte
H01M 4/36 - Selection of substances as active materials, active masses, active liquids
H01M 4/485 - Selection of substances as active materials, active masses, active liquids of inorganic oxides or hydroxides of mixed oxides or hydroxides for inserting or intercalating light metals, e.g. LiTi2O4 or LiTi2OxFy
H01M 4/505 - Selection of substances as active materials, active masses, active liquids of inorganic oxides or hydroxides of manganese of mixed oxides or hydroxides containing manganese for inserting or intercalating light metals, e.g. LiMn2O4 or LiMn2OxFy
H01M 4/525 - Selection of substances as active materials, active masses, active liquids of inorganic oxides or hydroxides of nickel, cobalt or iron of mixed oxides or hydroxides containing iron, cobalt or nickel for inserting or intercalating light metals, e.g. LiNiO2, LiCoO2 or LiCoOxFy
H01M 4/02 - Electrodes composed of, or comprising, active material
LE CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (France)
COLLEGE DE FRANCE (France)
Inventor
Tarascon, Jean-Marie
Ma, Jiwei
Bertry, Laure
Amisse, Robin
Braida, Marc-David
Le Mercier, Thierry
Buissette, Valérie
Abstract
The present invention relates to the new process of preparation of a Li-rich layered oxide based on Mn and optionally on Ni and/or Co in which F is incorporated within the crystal of the oxide (or "fluorinated oxide"). It also relates to the new fluorinated oxide its use as a component in a cathode of a battery.
H01M 4/505 - Selection of substances as active materials, active masses, active liquids of inorganic oxides or hydroxides of manganese of mixed oxides or hydroxides containing manganese for inserting or intercalating light metals, e.g. LiMn2O4 or LiMn2OxFy
H01M 4/525 - Selection of substances as active materials, active masses, active liquids of inorganic oxides or hydroxides of nickel, cobalt or iron of mixed oxides or hydroxides containing iron, cobalt or nickel for inserting or intercalating light metals, e.g. LiNiO2, LiCoO2 or LiCoOxFy
80.
PROCESS FOR THE HYDROXYLATION OF PHENOLIC DERIVATIVES CATALYZED BY HPAB MONOOXYGENASE
36166 hydroxycarboxyalkyl groups and alkoxycarbonyl groups of formula - COOR1, wherein R1166 alkyl group, said process comprising contacting in an aerobic aqueous and cell-free reaction medium said hydroxyphenyl compound with a HpaB monooxygenase in presence of (i) a flavin compound selected from FAD, FMN and mixtures thereof, (ii) a HpaC or Fre flavin reductase and (iii) a reducing agent being selected from a NADH compound or a NADPH compound.
ELECTROLYTE COMPOSITION INCLUDING A SPECIFIC COMBINATION OF ADDITIVES, ITS USE AS NON-AQUEOUS LIQUID ELECTROLYTE IN A NA-ION BATTERY AND NA-ION BATTERY INCLUDING SUCH AN ELECTROLYTE COMPOSITION
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (France)
COLLEGE DE FRANCE (France)
SORBONNE UNIVERSITÉ (France)
Inventor
Yan, Guochun
Tarascon, Jean-Marie
Abstract
The present invention relates to an electrolyte composition for a battery using sodium ions as electrochemical vector, to the use of such an electrolyte composition as non-aqueous liquid electrolyte in a sodium-ion battery and to a sodium-ion battery comprising such a non-aqueous liquid electrolyte.
The invention relates to a process for manufacturing a porous material comprising the following steps of providing incineration clinkers, providing an aqueous binder solution comprising at least one inorganic binder and/or at least one organic-inorganic hybrid binder, mixing said clinkers with said aqueous binder solution comprising at least one inorganic binder and/or at least one organic-inorganic hybrid binder, setting said mixture obtained by heat treatment and finally recovering the porous material thus manufactured. The manufacturing process thus makes it possible to recycle and upgrade the incineration clinkers by means of the production of a porous material. The process is particularly advantageous since the porous material may in particular be obtained very rapidly and may be used as insulating material or construction material.
C04B 26/32 - Compounds having one or more carbon-to-metal or carbon-to-silicon linkages containing silicon
C04B 28/24 - Compositions of mortars, concrete or artificial stone, containing inorganic binders or the reaction product of an inorganic and an organic binder, e.g. polycarboxylate cements containing alkyl ammonium or alkali metal silicatesCompositions of mortars, concrete or artificial stone, containing inorganic binders or the reaction product of an inorganic and an organic binder, e.g. polycarboxylate cements containing silica sols
83.
Use of engrailed proteins for increasing dopamine synthesis by dopaminergic neurons
Centre National de la Recherche Scientifique (France)
College de France (France)
Inventor
Prochiantz, Alain
Moya, Kenneth
Joshi, Rajiv
Abstract
The invention relates to the use of an Engrailed protein as a medicament for increasing dopamine synthesis by dopaminergic neurons, in particular in the management of conditions associated with a decrease of dopamine levels without loss of dopaminergic neurons.
A61K 38/17 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from animalsPeptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from humans
84.
METHOD FOR PRODUCING A MATERIAL WITH A LARGE SPECIFIC SURFACE
The invention relates to a method for producing a material with a large specific surface, comprising a step of atomising a liquid composition based on liquid residues from a chemical extraction of clinker, to a material based on clinker residues, characterised by a large specific surface of between 200 m2.g-1 and 900 m2.g-1 and a mesopore size of between 2 nm and 50 nm, and to the use of said materials for the absorption of contaminating species.
B01J 20/02 - Solid sorbent compositions or filter aid compositionsSorbents for chromatographyProcesses for preparing, regenerating or reactivating thereof comprising inorganic material
B01J 20/10 - Solid sorbent compositions or filter aid compositionsSorbents for chromatographyProcesses for preparing, regenerating or reactivating thereof comprising inorganic material comprising silica or silicate
B01J 20/30 - Processes for preparing, regenerating or reactivating
B01J 20/28 - Solid sorbent compositions or filter aid compositionsSorbents for chromatographyProcesses for preparing, regenerating or reactivating thereof characterised by their form or physical properties
85.
METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT PATIENTS SUFFERING FROM MYELOPROLIFERATIVE DISORDERS
INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE) (France)
UNIVERSITÉ PARIS DIDEROT - PARIS 7 (France)
ASSISTANCE PUBLIQUE-HÔPITAUX DE PARIS (APHP) (France)
UNIVERSITÉ PARIS-SUD (France)
INSTITUT GUSTAVE ROUSSY (France)
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (France)
COLLEGE DE FRANCE (France)
Inventor
De The, Hugues
Cassinat, Bruno
Lallemand-Breitenbach, Valérie
Plo, Isabelle
Villeval, Jean-Luc
Kiladjian, Jean-Jacques
Abstract
The present invention relates to methods and pharmaceutical compositions for the treatment of myeloproliferative disorders in patients presenting a dysregulation of the JAK2-STAT signalling pathway. Using MPN mouse model and clonogenic methyl-cellulose cultures of patient progenitors, the inventors demonstrate that combining ARS with IFN improves most of the benefits provided by IFN alone during MPN treatment. In particular, the present invention relates to a method of treating a myeloproliferative disorder in a patient presenting a dysregulation of the JAK2-STAT signalling pathway comprising administering to the patient a therapeutically effective combination of an interferon polypeptide and an arsenic compound.
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (France)
COLLEGE DE FRANCE (France)
Inventor
Droulez, Jacques
Bessiere, Pierre
Abstract
The invention relates to a stochastic-type microprocessor.
In some embodiments, the microprocessor comprises an elementary stochastic computation module able to receive, as input, two random and independent binary input signals each representing a binary coding of two respective given input probability values, and able to generate, as output, a random binary output signal.
a second stochastic clock, able to produce a second clock signal.
G06F 7/70 - Methods or arrangements for performing computations using a digital non-denominational number representation, i.e. number representation without radixComputing devices using combinations of denominational and non-denominational quantity representations using stochastic pulse trains, i.e. randomly occurring pulses the average pulse rates of which represent numbers
G06F 7/58 - Random or pseudo-random number generators
87.
Method to synthesize Na-based electroactive materials
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (France)
UNIVERSITE TOULOUSE III—PAUL SABATIER (France)
SORBONNE UNIVERSITE (France)
COLLEGE DE FRANCE (France)
Inventor
Tarascon, Jean-Marie
Rozier, Patrick
Zhang, Biao
Dugas, Romain
Abstract
The invention relates to a process for the preparation of sodium-based solid compounds, such as sodium-based solid alloys and sodium-based crystalline phases by ball-milling using metallic sodium as starting material.
3, obtained by such a process and to their use, as active material for positive electrode, in a Na-ion battery.
H01M 4/58 - Selection of substances as active materials, active masses, active liquids of inorganic compounds other than oxides or hydroxides, e.g. sulfides, selenides, tellurides, halogenides or LiCoFySelection of substances as active materials, active masses, active liquids of polyanionic structures, e.g. phosphates, silicates or borates
B22F 9/00 - Making metallic powder or suspensions thereofApparatus or devices specially adapted therefor
C22C 1/04 - Making non-ferrous alloys by powder metallurgy
B22F 9/04 - Making metallic powder or suspensions thereofApparatus or devices specially adapted therefor using physical processes starting from solid material, e.g. by crushing, grinding or milling
C22C 24/00 - Alloys based on an alkali or an alkaline earth metal
H01M 10/054 - Accumulators with insertion or intercalation of metals other than lithium, e.g. with magnesium or aluminium
H01M 4/505 - Selection of substances as active materials, active masses, active liquids of inorganic oxides or hydroxides of manganese of mixed oxides or hydroxides containing manganese for inserting or intercalating light metals, e.g. LiMn2O4 or LiMn2OxFy
H01M 4/525 - Selection of substances as active materials, active masses, active liquids of inorganic oxides or hydroxides of nickel, cobalt or iron of mixed oxides or hydroxides containing iron, cobalt or nickel for inserting or intercalating light metals, e.g. LiNiO2, LiCoO2 or LiCoOxFy
H01M 4/587 - Carbonaceous material, e.g. graphite-intercalation compounds or CFx for inserting or intercalating light metals
H01B 1/02 - Conductors or conductive bodies characterised by the conductive materialsSelection of materials as conductors mainly consisting of metals or alloys
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (France)
COLLEGE DE FRANCE (France)
UNIVERSITE DE POITIERS (France)
Inventor
Portehault, David
Gouget, Guillaume
Sanchez, Clément
Beauchet, Romain
Batonneau, Yann
Kappenstein, Charles
Abstract
The invention relates to a solid energetic composition comprising at least one oxidizing charge and at least one nanostructured material essentially consisting of boron, said material being in amorphous form and comprising clusters of boron nanoparticles, to the process for preparing same, to a propellant comprising such a solid energetic composition and also to the uses of said composition and of said propellant, in particular in the field of space propulsion, in the motor vehicle field, in particular in airbag inflation systems or any other gas-generating system, including protective gas-generating systems, or in the field of generating high pressures for the manufacture of materials, for example for the manufacture of diamond.
C06B 45/00 - Compositions or products which are defined by structure or arrangement of component or product
C06B 47/10 - Compositions in which the components are separately stored until the moment of burning or explosion, e.g. "Sprengel"-type explosivesSuspensions of solid component in a normally non-explosive liquid phase, including a thickened aqueous phase the components comprising a binary propellant a component containing free boron, an organic borane or a binary compound of boron, except with oxygen
C06D 5/06 - Generation of pressure gas, e.g. for blasting cartridges, starting cartridges, rockets by reaction of two or more solids
89.
SOL-GEL METHOD FOR PRODUCING AN ANTI-CORROSION COATING ON A METAL SUBSTRATE
UNIVERSITE PIERRE ET MARIE CURIE (PARIS 6) (France)
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE - CNRS - (France)
COLLEGE DE FRANCE (France)
Inventor
Astorg, Adèle
Crozes, Xavier
Nicole, Lionel
Sanchez, Clément
Abstract
The invention relates to a sol-gel method for producing an anti-corrosion coating consisting of at least one layer (31, 32) of an oxide on a metal substrate (10). A non-aqueous solution (1) of a precursor of the oxide is prepared (SI) and deposited (S2) on one surface (11) at least of the metal substrate in order to cover said surface at least partially with a film (20) comprising the precursor of the oxide. Hydrolysis-condensation of the precursor of the oxide is carried out (S3) by exposing the film to a humid atmosphere in order to form an oxide network in the film. Then, a treatment for stabilising the film on the surface of the substrate is carried out (S4), followed by a heat treatment (S5) of the surface of the metal substrate in order to crystallise the network of oxide and form the anti-corrosion coating.
C23C 18/12 - Chemical coating by decomposition of either liquid compounds or solutions of the coating forming compounds, without leaving reaction products of surface material in the coatingContact plating by thermal decomposition characterised by the deposition of inorganic material other than metallic material
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (France)
COLLEGE DE FRANCE (France)
Inventor
Sanchez, Clément
Gervais Stary, Christel
Portehault, David
Gouget, Guillaume
Abstract
A nanostructured material consisting essentially of boron. The material is in amorphous form and comprising aggregates of boron nanoparticles. A method of preparation thereof and the uses thereof.
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (France)
COLLEGE DE FRANCE (France)
UNIVERSITE DE VALENCIENNES ET DU HAINAUT CAMBRESIS (France)
UNIVERSITE DE CAEN NORMANDIE (France)
Inventor
Portehault, David
Marinel, Sylvain
Savary, Etienne
Abstract
A method for melting a sample comprising at least one salt in a microwave cavity, said cavity being at least formed by an enclosure of which the geometry is suitable for resonance, in a single mode, of a stationary electromagnetic field, defining at least one local extremum of the electric or magnetic field in said cavity, said cavity comprising at least one movable reflective face (8, 9), the position of which can be adjusted in such a way as to modify the geometry of the microwave cavity, said sample being arranged in a hollow insert, said method comprising at least the steps consisting of placing said sample or samples in said insert in such a way as to make the arrangement of said sample correspond with one said extremum, emitting microwaves at the frequency ν0 in said cavity, detecting the power reflected in said cavity and adjusting the position of said or at least one said reflective face and/or the frequency of the microwaves in such a way as to minimise said detected power.
B01J 19/12 - Processes employing the direct application of electric or wave energy, or particle radiationApparatus therefor employing electromagnetic waves
INSERM - INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE (France)
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (France)
COLLÈGE DE FRANCE (France)
Inventor
Bonnet, Dominique
Llorens Cortes, Catherine
Iturrioz, Xavier
Abstract
The present invention relates to metabolically stable and non- immunogen analogs completely hydrosolubleat physiological pH, and their use for the prevention or treatment of diseases mediated by G-protein coupled receptor (GPCR), in particular (Central Nervous System) CNS and cardiovascular diseases or disorders, or their use in diagnostic methods.
C07K 14/435 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from animalsPeptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from humans
93.
Use of a reverse-transcriptase inhibitor in the prevention and treatment of degenerative diseases
C12N 15/113 - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides
C12Q 1/68 - Measuring or testing processes involving enzymes, nucleic acids or microorganismsCompositions thereforProcesses of preparing such compositions involving nucleic acids
C12N 15/63 - Introduction of foreign genetic material using vectorsVectorsUse of hosts thereforRegulation of expression
C12Q 1/25 - Measuring or testing processes involving enzymes, nucleic acids or microorganismsCompositions thereforProcesses of preparing such compositions involving enzymes not classifiable in groups
94.
HOMEOPROTEINS FOR USE IN THE TREATMENT OF NEURODEGENERATIVE DISORDERS
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (France)
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (France)
COLLEGE DE FRANCE (France)
SORBONNE UNIVERSITÉ (France)
Inventor
Prochiantz, Alain
Abstract
The present invention relates to the use of a homeoprotein or a recombinant vector encoding said protein for treating or preventing DNA damage and/or cellular aging. In particular, the invention concerns the use of Engrailed for the treatment of Parkinson disease.
A61K 38/17 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from animalsPeptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from humans
A61P 25/00 - Drugs for disorders of the nervous system
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (France)
COLLEGE DE FRANCE (France)
Inventor
Droulez, Jacques
Bessiere, Pierre
Abstract
The invention relates to a stochastic-type microprocessor. The microprocessor comprises an elementary stochastic computation module (1) able to receive as input two random and independent binary input signals (A, B) each representing a binary coding of two respective given input probability values, and able to generate as output a random binary output signal (C). The elementary module comprises: - a programmable logic unit (2), able to combine two input signals (A, B) to generate an output signal (C); an addressable memory (3), able to store an output probability value coded by an output signal (C) generated by the logic unit (2); - a first stochastic clock (4), able to produce a first clock signal (CLK1); - and a second stochastic clock (5) able to produce a second clock signal (CLK2).
G06F 7/70 - Methods or arrangements for performing computations using a digital non-denominational number representation, i.e. number representation without radixComputing devices using combinations of denominational and non-denominational quantity representations using stochastic pulse trains, i.e. randomly occurring pulses the average pulse rates of which represent numbers
96.
METHOD FOR PREPARING TRANSPARENT COLLAGEN MATRICES
UNIVERSITE PIERRE ET MARIE CURIE (PARIS 6) (France)
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (France)
ECOLE PRATIQUE DES HAUTES ETUDES (France)
COLLEGE DE FRANCE (France)
Inventor
Nassif, Nadine
Giraud-Guille, Marie-Madeleine
Wang, Yan
Robin, Marc
Salviat, Flore
Abstract
The present invention relates to a method for preparing a transparent fibrillar collagen matrix capable of being used as a tissue substitute for producing a tissue or an artificial organ, in particular a cornea substitute.
UNIVERSITE PIERRE ET MARIE CURIE (PARIS 6) (France)
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (France)
COLLEGE DE FRANCE (France)
Inventor
Portehault, David
Gouget, Guillaume
Gervais Stary, Christel
Sanchez, Clément
Abstract
The invention concerns a nanostructured material essentially consisting of boron, said material being in amorphous form and comprising aggregates of boron nanoparticles, the methods for preparing same and the uses thereof.
INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE) (France)
COLLEGE DE FRANCE (France)
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (France)
UNIVERSITÉ PARIS-EST CRÉTEIL VAL DE MARNE (France)
ASSISTANCE PUBLIQUE-HÔPITAUX DE PARIS (APHP) (France)
ECOLE NATIONALE VÉTÉRINAIRE D‘ALFORT (ENVA) (France)
Inventor
Germain, Stéphane
Berdeaux, Alain
Tissier, Renaud
Ghaleh-Marzban, Bijan
Monnot, Catherine
Galaup, Ariane
Abstract
The present invention relates to methods and pharmaceutical compositions for the treatment of ischemic conditions. In particular, the present invention relates to a method of treating an ischemic condition in a subject in need thereof comprising administering the subject with a polypeptide comprising an amino acid sequence having at least 70% of identity with the amino acid sequence ranging from the amino acid residue at position 186 to the amino acid residue at position 406 in SEQ ID NO: 1.
A61K 38/17 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from animalsPeptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from humans
A61P 9/10 - Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE) (France)
COLLEGE DE FRANCE (France)
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (France)
UNIVERSITÉ DE STRASBOURG (France)
Inventor
Llorens-Cortes, Catherine
Bonnet, Dominique
Iturrioz, Xavier
Abstract
The invention is related to metabolically stable apelin analogs and their use for the prevention or the treatment of diseases mediated by the apelin receptor in particular of cardiovascular disease (heart failure, hypertension, pulmonary hypertension, kidney failure) and inappropriate vasopressin secretions (SIADH).
C07K 7/08 - Linear peptides containing only normal peptide links having 12 to 20 amino acids
C07K 14/47 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from animalsPeptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from humans from vertebrates from mammals
The present invention pertains to a fluoropolymer film comprising at least one fluoropolymer hybrid organic/inorganic composite [polymer (FH)], to a process for the manufacture of said fluoropolymer film and to uses of said fluoropolymer film in various applications, in particular in electrochemical applications.